Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
Palumbo
Antonio
A
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria (A.O.U.) S. Giovanni Battista, Torino, Italy. appalumbo@yahoo.com
Bringhen
Sara
S
Rossi
Davide
D
Cavalli
Maide
M
Larocca
Alessandra
A
Ria
Roberto
R
Offidani
Massimo
M
Patriarca
Francesca
F
Nozzoli
Chiara
C
Guglielmelli
Tommasina
T
Benevolo
Giulia
G
Callea
Vincenzo
V
Baldini
Luca
L
Morabito
Fortunato
F
Grasso
Mariella
M
Leonardi
Giovanna
G
Rizzo
Manuela
M
Falcone
Antonietta Pia
AP
Gottardi
Daniela
D
Montefusco
Vittorio
V
Musto
Pellegrino
P
Petrucci
Maria Teresa
MT
Ciccone
Giovannino
G
Boccadoro
Mario
M